Literature DB >> 24050140

Multi-objective optimization methods in drug design.

Christos A Nicolaou, Nathan Brown.   

Abstract

Drug discovery is a challenging multi-objective problem where numerous pharmaceutically important objectives need to be adequately satisfied for a solution to be found. The problem is characterized by vast, complex solution spaces further perplexed by the presence of conflicting objectives. Multi-objective optimization methods, designed specifically to address such problems, have been introduced to the drug discovery field over a decade ago and have steadily gained in acceptance ever since. This paper reviews the latest multi-objective methods and applications reported in the literature, specifically in quantitative structure–activity modeling, docking, de novo design and library design. Further, the paper reports on related developments in drug discovery research and advances in the multi-objective optimization field.

Mesh:

Substances:

Year:  2013        PMID: 24050140     DOI: 10.1016/j.ddtec.2013.02.001

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  17 in total

Review 1.  From flamingo dance to (desirable) drug discovery: a nature-inspired approach.

Authors:  Aminael Sánchez-Rodríguez; Yunierkis Pérez-Castillo; Stephan C Schürer; Orazio Nicolotti; Giuseppe Felice Mangiatordi; Fernanda Borges; M Natalia D S Cordeiro; Eduardo Tejera; José L Medina-Franco; Maykel Cruz-Monteagudo
Journal:  Drug Discov Today       Date:  2017-06-15       Impact factor: 7.851

2.  Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topology.

Authors:  Ramon Garcia-Domenech; Riccardo Zanni; Maria Galvez-Llompart; Jorge Galvez
Journal:  Mol Divers       Date:  2015-03-10       Impact factor: 2.943

Review 3.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

Review 4.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

5.  A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.

Authors:  Scarlet Milo; Rachel A Heylen; John Glancy; George T Williams; Bethany L Patenall; Hollie J Hathaway; Naing T Thet; Sarah L Allinson; Maisem Laabei; A Toby A Jenkins
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

6.  Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.

Authors:  Martin Klammer; J Nikolaj Dybowski; Daniel Hoffmann; Christoph Schaab
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

7.  Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency.

Authors:  Kai-Cheng Hsu; Feng-Sheng Wang
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

8.  Does Size Really Matter? Probing the Efficacy of Structural Reduction in the Optimization of Bioderived Compounds - A Computational "Proof-of-Concept".

Authors:  Fisayo A Olotu; Geraldene Munsamy; Mahmoud E S Soliman
Journal:  Comput Struct Biotechnol J       Date:  2018-11-23       Impact factor: 7.271

9.  SAR and QSAR modeling of a large collection of LD50 rat acute oral toxicity data.

Authors:  Domenico Gadaleta; Kristijan Vuković; Cosimo Toma; Giovanna J Lavado; Agnes L Karmaus; Kamel Mansouri; Nicole C Kleinstreuer; Emilio Benfenati; Alessandra Roncaglioni
Journal:  J Cheminform       Date:  2019-08-30       Impact factor: 5.514

10.  On the origins of three-dimensionality in drug-like molecules.

Authors:  Joshua Meyers; Michael Carter; N Yi Mok; Nathan Brown
Journal:  Future Med Chem       Date:  2016-08-30       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.